Concordia Laboratories - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsConcordia Laboratories

Concordia Laboratories

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Dibenzyline	Phenoxybenzamine	1982-01-01		Malignant hypertension , Pheochromocytoma , Urinary bladder neck obstruction , Urinary incontinence
Dutoprol	Hydrochlorothiazide, Metoprolol	2006-08-28	2023-2028	Essential hypertension , Hypertension , Edema , Heart failure , Nephrotic syndrome
Dyrenium	Triamterene	1982-01-01		Edema , Hypertension , Hypokalemia
Kapvay	Clonidine	2009-09-30	2027-2031	Attention deficit disorder with hyperactivity , Diarrhea , Dysmenorrhea , Glaucoma , Hot flashes , Hypertension , Intractable pain , Muscle spasticity , Nervous system alcohol-induced disorders , Sialorrhea , Substance withdrawal syndrome , Tourette syndrome
Kayexalate	Polystyrene sulfonate	1982-01-01		Hyperkalemia
Lanoxin	Digoxin	1997-09-30		Anxiety disorders, Atrial fibrillation, Atrial flutter, Cardiogenic shock, Heart failure, Low cardiac output, Supraventricular tachycardia
Nilandron	Nilutamide	1996-09-19		Carcinoma, Prostatic neoplasms
Orapred	Prednisolone	2000-12-14	2028	Adrenal insufficiency, Ankylosing spondylitis, Asthma, Atopic dermatitis, Berylliosis, Brain neoplasms, Collagen diseases, Conjunctivitis, Dermatitis herpetiformis, Edema, Erythema multiforme, Hemolytic anemia, Hypercalcemia, Inflammation, Leukemia, Multiple sclerosis, Mycosis fungoides, Nephrotic syndrome, Pemphigus, Pulmonary tuberculosis, Rheumatic diseases, Sarcoidosis, Serum sickness, Synovitis, Systemic lupus erythematosus, Thrombocytopenia, Thyroiditis, Ulcerative colitis, Uveitis
Panretin	Alitretinoin	1999-02-02		Kaposi sarcoma, Skin diseases
Parnate	Tranylcypromine	1985-08-16		Depressive disorder, Post-traumatic stress disorders
Plaquenil	Hydroxychloroquine	1982-01-01		Malaria, Photosensitivity disorders, Porphyria cutanea tarda, Rheumatic diseases, Rheumatoid arthritis, Systemic lupus erythematosus
Salagen	Pilocarpine	1994-03-22	2039	Angle-closure glaucoma, Head and neck neoplasms, Mydriasis, Xerostomia
Uroxatral	Alfuzosin	2003-06-12		Prostatic hyperplasia
Zonegran	Zonisamide	2000-03-27	2038	Epilepsy, Partial epilepsies

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

attention deficit disorder with hyperactivity

Antithrombin iii

non-small-cell lung carcinoma

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use